Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S ADR (NY: NVO )

140.80 +0.43 (+0.31%)
Official Closing Price Updated: 7:00 PM EDT, Jun 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,640,228
Open 141.06
Bid (Size) 139.53 (1)
Ask (Size) 142.00 (1)
Prev. Close 140.37
Today's Range 139.78 - 141.71
52wk Range 75.56 - 144.50
Shares Outstanding N/A
Dividend Yield 1.26%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
7 Stocks With Impressive Earnings Growth: Real or Engineered?
These growth stocks have shown impressive earnings increases but not all earnings growth is the same so investors must pay attention. 
Via InvestorPlace
Eli Lilly Hits All-Time High, Named To Big Cap 20 List: Check These Lists For Best Stocks To Buy
Eli Lilly stock has been on an astounding run. In 2009 its stock sold for 27.21 a share. It closed Tuesday at 891.46, up 3,149% from 2009. 
Via Investor's Business Daily

Performance

YTD
+37.89%
+37.89%
1 Month
+5.94%
+5.94%
3 Month
+7.18%
+7.18%
6 Month
+40.81%
+40.81%
1 Year
+74.18%
+74.18%

More News

Read More
3 Mega Cap Stock Bargains As Markets Hit All-Time Highs
Via Benzinga
Obesity In Children - US Parents Face Tough Time To Access Recommended Treatment, Though Novo Nordisk's Drug Still Sees Strong Demand
Via Benzinga
The Best Biotech Stock to Invest $1,000 in Right Now
Via The Motley Fool
$100 Invested In This Stock 10 Years Ago Would Be Worth $600 Today
Via Benzinga
Novo Nordisk Unusual Options Activity For June 13
Via Benzinga
Gilead Has A Narrative-Changing Revelation For Its Weight-Loss Contender
Via Investor's Business Daily
Could Structure Therapeutics Become the Next Novo Nordisk?
Via The Motley Fool
3 Best Stocks to Buy From the Fantastic 5
Via InvestorPlace
Week Of June 16: What's In Store For The Markets
Via Talk Markets
Where Will Madrigal Pharmaceuticals Be in 3 Years?
Via The Motley Fool
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
Via The Motley Fool
Gilead Sciences Jumps After Its Weight-Loss Drug Emerges From Under The Radar
Via Investor's Business Daily
7 A-Rated Biotech Stocks Worth Betting on in June
Via InvestorPlace
3 Stocks to Sell as Ozempic Surges in Popularity
Via InvestorPlace
Got $200? 2 Healthcare Stocks to Buy and Hold Forever.
Via The Motley Fool
Wegovy's Precarious Position: 3 Drugs Most Likely to Dethrone Novo Nordisk's Blockbuster Obesity Drug
Via The Motley Fool
Weight Loss Drugs: Are They Really Magic?
Via The Motley Fool
JPMorgan's $500M Venture Capital Fund Bets Big On Weight-Loss Drugs: 'They're All The Rage'
Via Benzinga
3 Stocks to Buy as Ozempic Surges in Popularity
Via InvestorPlace
Ozempic Maker Novo Nordisk Closes In On Lego As Denmark's Most Valuable Brand: Report
Via Benzinga
Humans Clamor For Weight Loss Drugs, But The Next Users Could Be... Pets?
Via Benzinga
7 Trending Stocks With Momentum on Their Side
Via InvestorPlace
Is Eli Lilly the Best Pharmaceutical Stock for You?
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.